Dr. Kevin Zorn is a dual-board-certified (US and Canada), minimally-invasive uro-oncology, fellowship trained urologist at the University of Chicago. His main focus of clinical and scientific interest is in the surgical treatment of renal and prostate cancer. He is also an expert in performing surgery with the DaVinci Surgical Robotic System to manage localized prostate cancer and small renal masses. Dr. Zorn studied medicine and urology at McGill University in Montréal.
Dr. Zorn is an active researcher and a dedicated teacher to his urology residents and fellows. Other research interests include surgical, cancer-control and quality-of-life out outcomes after radical prostatectomy for prostate cancer. Dr. Zorn has published extensively in this subject and has received awards for his clinical work, research and teaching from the Endourological Society. He is also a reviewer for many urological journals and has been awarded Best Reviewer for Prostate Cancer in 2009 for the Journal of Urology. He is also a member of the AUA educational task force for the development of the laparoscopic and robotic urologic surgery curriculum and continues to be the AUA hands-on course director for the annual AUA annual meetings.
Dr. Zorn has also helped develop and organize the annual University of Chicago Robotic Radical Prostatectomy Course (a symposium of the world's top robotic surgeons) which began in 2007 (http://rlrpcourse.uchicago.edu). He also assisted Dr. Shalhav in hosting the 2010 World Congress of Endourology Meeting which took place in Chicago. In March 2009, Dr. Zorn took over the role of Chief of Urology at Weiss Memorial Hospital.
Recently, Dr. Zorn has returned home to Montréal to develop the robotic urological program at the University of Montréal where he serves as Assistant Professor of Surgery and Director of Robotic Surgery. His practice is focused on minimally invasive robotic and laser surgery for prostate pathology. He was the first in Canada to utilize the latest version of the Greenlight 180W XPS laser for BPH. He is active in the MIS urology program focusing on hands-on simulation and training.